Intrauterine 5-Aminolevulinic Acid Induces Selective Endometrial Fluorescence in the Rhesus and Cynomolgus Monkey

Abstract

Objectives: To evaluate the selectivity of endometrial photosensitization after intrauterine 5-aminolevulinic acid administration in nonhuman primates, and to assess acute and chronic systemic toxicity after intravenous (IV) delivery of 5-aminolevulinic acid.

Methods: Ovariectomized cynomolgus monkeys (n = 19) aged 6-18 years and ovariectomized rheusus monkeys (n = 3) aged 9-14 years were used in these studies. 5-aminolevulinic acid at various doses was administered by a transfundal (n = 8), transcervical (n = 3), or IV (n = 11) route. Spectrophotofluorometric readings and fluorescence microscopy were used to assess 5-aminolevulinic acid-induced photosensitization of uterine tissues; respiration, heart rate, blood biochemistry, and behavior were used to evaluate potential acute and delayed systemic toxicity.

Results: Endometrial fluorescence was achieved in all animals after administration of 5-aminolevulinic acid. Characteristic spectrophotofluorescence peaks of protoporphyrin IX (PpIX) in the endometrium but not myometrium confirmed selective endometrial PpIX production from 5-aminolevulinic acid. A transient (less than 1 week) increase in serum aspartate aminotransferase was observed after systemic instillation of 5-aminolevulinic acid in dosage 24-50-fold greater than that required to induce endometrical photosensitization after intrauterine injection.

Conclusions: The endometrium but not myometrium in nonhuman primates is capable of converting 5-aminolevulinic acid into protoporphyrin IX. At large doses, systemic 5-aminolevulnic acid causes a transient increase in the serum aspartate aminotransferase level. No other evidence of acute or delayed systemic toxicity was observed.

Keywords

5-Aminolevulinic acid photosensitization endometrium rhesus and cynomolgus monkey

Get full access to this article

View all access options for this article.

References

1. Scott PC . The outcome of menorrhagia: A retrospective case control study. J. Roy Coll Gen Pract 1983;33:715-720.

2. Boyd ME . Dysfunctional uterine bledding. Can J Surg 1986;29:305-307.

3. Carlson KJ , Miller BA , Fowler FJ . The Maine Women's Health Study: II. Outcomes of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstet Gynecol 1994;83:566-572.

4. Pokras R , Hufnagel VG . Hysterectomy in the United States 1965-1984. Am J Public Health 1988;78:852-853.

5. Dicker RC , Greenspan JR , Strauss LT , et al. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. Am J Obstet Gynecol 1982;144:841-848.

6. Copperman AB , DeCherney AH , Olive DL . A case of endometrial cancer following endometrial ablation for dysfunctional uterine bleeding. Obstet Gynecol 1993;82:640-642.

7. Kennedy JC , Pottier RH . Endogenous protoporphyrin IX: A clinically useful photosensitizer for photodynamic therapy. J. Photochem Photobiol [B] 1992;14:275-292.

8. Schneider DF , Schellhas HF , Wesseler TA , Molton BC . Endometrial ablation by dihematoporophrin ether photoradiation therapy in estrogen-treated ovariectomized rats. Colposc Gynecol Laser Surg 1988;4:73-77.

9. Yang JZ , Van Vugt DA , Kennedy JC , Reid RL . Intrauterine 5-aminolevulinic acid induces selective fluorescence and photodynamic ablation of the rat endometrium. Photochem Photobiol 1993;57:803-807.

10.

10. Yang JZ , Van Vugt DA , Kennedy JC , Reid RL . Evidence of lasting functional destruction of the rat endometrium following 5-aminolevulinic acid-induced photodynamic ablation: Prevention of implantation. Am J Obstet Gynecol 1993;168:995-1001.

11.

11. Wyss P , Tromberg BT , Wyss MT , et al. Photodynamic destruction of endometrial tissue with topical 5-aminolevulinic acid in rats and rabbits. Am J Obstet Gynecol 1994;171:1176-1183.

12.

12. Pottier RH , Chow YFA , LaPlante JP , Truscott TG , Kennedy JC . Noninvassive technique for obtaining fluorescence excitation and emission spectra in vivo. Photochem Photobiol 1986;44:679-687.

13.

13. Goldrath MH , Fuller TA , Segal S . Laser photovaporization of endometrium for the treatment of menorrhagia. Am J Obstet Gynecol 1981;140:14-19.

14.

14. DeCherney AH , Diamond MP , Lavy G , Polan ML . Endometrial ablation for intractable uterine bleeding: Hysteroscopic resection. Obstet Gynecol 1987;70:668-670.

15.

15. Dwyer N , Hutton J , Strirrat GM . Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. Bri J Obstet Gynaecol 1993;100:237-243.

16.

16. Loffer FD . Hysteroscopic endometrial ablation with Nd:YAG laser using a nontouch technique. Obstet Gynecol 1987;69:679-682.

17.

17. Baggish MS , Baltoyannis P . New technique for laser ablationi of the endometrium in high-risk patients. Am J Obstet Gynecol 1988;159:287-292.

18.

18. Bridgman SA . Increasing operative rates for dysfunctional uterine bleeding after endometrial ablation. Lancet 1994;344:893-893.

19.

19. Kennedy JC , Nadeua P , Petryka ZJ , Pottier RH , Weagle G . Clearance times of porphyrin derivatives from mice as measured by in vivo fluorescence spectroscopy. Photochem Photobiol 1992;55:729-734.

20.

20. Wooten RS , Smith KC , Ahlquist DA , Muller SA , Balm RK . Prospective study of cutaneous phototoxicity after systemic hematoporphyrin derivative. Lasers Surg Med 1988;8:294-300.

21.

21. Dougherty TJ , Cooper MT , Mang TS . Cutaneous phototoxic occurrences in patients receiving Photofrin II. Lasers Surg Med 1990;10:485-488.

22.

22. Mustajoki P , Timonen K , Gorchein A , et al. Sustained high plasma 5-aminolevulinic acid concentration in a volunteer: No porphyric symptoms. Eur J Clin Invest 1992;22:407-411.